Eli Lilly keeps dividend steady, shares trade near record levels on NYSE
23.06.2026 - 23:06:53 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 23:05.
Eli Lilly & Co. (US5324571083) underpins its income profile with a steady third-quarter cash dividend while the shares continue to trade near record territory on the NYSE, supported by a broadly positive analyst stance. The board confirmed a quarterly payout of $1.73 per share, payable on September 10 to holders of record on August 14, according to the latest company communication and market data.
Dividend decision and cash return
Eli Lilly has kept its regular quarterly dividend at $1.73 per share for the third quarter of 2026, mirroring the previous distribution earlier in the year, according to recent market reports summarizing the company’s announcement.Hargreaves Lansdown dividend overview for Eli Lilly The ex-dividend date for the upcoming payment is set for August 14, with cash scheduled to be distributed on September 10, which provides investors with a clear timetable for the income stream.
Maintaining the dividend at this level translates into a forward dividend yield of roughly 0.6 to 0.7 percent based on current trading levels, as indicated by several price and yield snapshots from market data providers.Robinhood key figures for Eli Lilly shares While modest compared with classical high-yield sectors, the payout reflects a focus on growth and reinvestment, with the dividend acting more as a stability signal than as the main equity attraction.
Analyst consensus and valuation picture
Alongside the dividend confirmation, the analyst consensus on Eli Lilly remains clearly skewed toward a positive view, with 24 out of 29 analysts currently rating the stock as a Buy, five as Hold and only two as Sell, according to a recent compilation of forecasts.Investing.com consensus estimates for Eli Lilly The average 12-month price target sits at about $1,218.72, with the range stretching from roughly $850 on the downside to $1,500 at the top, illustrating both confidence in the pipeline and some dispersion of views on valuation.
On the trading side, Eli Lilly shares are quoted around the $1,100 mark on the NYSE, only a single-digit percentage below the 52-week high of approximately $1,182.73 reached in early June 2026, as shown by recent market price histories.Financial Times market summary for LLY on NYSE This keeps the market capitalization in the range of about $1.0 trillion, which positions Eli Lilly among the most valuable healthcare stocks globally and makes the company a heavyweight component in major US indices such as the S&P 500 and often a reference point in sector comparisons against peers like Novo Nordisk, Johnson & Johnson or Pfizer.
All news and analysis on the Eli Lilly shares
Further updates, background pieces and detailed price data on Eli Lilly & Co. are available in the dedicated topic section and on the company’s investor relations page.
The products behind the valuation
Eli Lilly generates most of its revenue from prescription medicines in areas such as diabetes, obesity, oncology and immunology, with several flagship brands driving growth. The diabetes drug Trulicity and newer obesity therapies based on the GLP-1 and GIP mechanisms, including Mounjaro and its successors, have become central to the company’s sales trajectory in recent years, according to public product portfolios and sector coverage.Eli Lilly product information Alongside these, cancer treatments and autoimmune disease therapies contribute meaningful revenue streams and underpin the research focus.
Where the Eli Lilly shares trade today
The Eli Lilly & Co. shares (US5324571083) trade on 2026-06-23 at around $1,106.74 on the NYSE in US dollars, leaving the stock approximately 6 to 7 percent below the 52-week high set earlier in June and reflecting a market capitalization close to $1.0 trillion based on recent price and share count data.
Key data on the Eli Lilly shares
- Company: Eli Lilly and Company
- ISIN: US5324571083
- WKN: 858560
- Ticker: LLY
- Trading venue: NYSE
- Price (as of 2026-06-23, 23:05): 1,106.74 USD
- Market cap: 1.04 trillion USD (as of 2026-06-23)
- Sector / industry: Health Care / Pharmaceuticals
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This text is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell securities. All data and assessments are based on sources believed to be reliable at the time of publication but may change without notice.
